Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 9 of 9 for “"Intravesical therapy"”.

  1. An Epidemiology Study of Prognositic Factors for Non-Muscle Invasive Bladder Cancer

    … on the stage and grade of the cancer, an intravesical therapy may be followed. Intravesical therapy with Bacillus Calmette-Guerin (BCG) after TURBT is the gold standard therapy to prevent or delay recurrence/progression, but it has a 20-40% failure rate and various adverse effects. …

    buffalo Repository record for An Epidemiology Study of Prognositic Factors for Non-Muscle Invasive Bladder Cancer (opens in a new tab)

  2. The investigation of the properties and behaviour of superficial bladder cancer by an in vitro explant tumour system, and its use in the response to conventional and novel intravesical cytotoxic agents /cTimothy John Crook.

    … for the assessment of therapeutic agents used as intravesical therapy, and which is consistent and amenable to rationalised experiments.</p> <p><i>Introduction:</i> Superficial transitional cell carcinoma of the bladder is more common compared to the invasive type, but has a high probability of …

    soton Download PDF for The investigation of the properties and behaviour of superficial bladder cancer by an in vitro explant tumour system, and its use in the response to conventional and novel intravesical cytotoxic agents /cTimothy John Crook. (opens in a new tab)

  3. Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer

    … prognosis and is treated by tumor resection and intravesical therapy, whereas muscle-invasive BC has poor prognosis and requires radical cystectomy combined with cisplatin-based chemotherapy. High- throughput sequencing technologies allow identification of individual molecular signatures to …

    fu-berlin Repository record for Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer (opens in a new tab)

  4. Η επίδραση των ενδοκυστικών εγχύσεων επιρουμπικίνης και ιντερφερόνης α - 2b στα κύτταρα του ανοσοποιητικού συστήματος στο τοίχωμα της ουροδόχου κύστης

    Objective: To investigate the effect of intravesical instillations of epirubicin and interferon a-2b, alone or in combination upon the numbers of immune cells in the bladder wall. As far as the combination is concerned we investigated the hypothesis that epirubicin might facilitate the action of …

    greece Repository record for Η επίδραση των ενδοκυστικών εγχύσεων επιρουμπικίνης και ιντερφερόνης α - 2b στα κύτταρα του ανοσοποιητικού συστήματος στο τοίχωμα της ουροδόχου κύστης (opens in a new tab)

  5. Mechanisms of action of Manuka honey as a potential therapeutic agent for bladder pain syndrome/interstitial cystitis: clinical and laboratory studies

    … properties. Thus, it might be a useful adjuvant therapy for BPS/IC. The aims of this study were to investigate the link between neurogenic inflammation in the pathophysiology of BPS/IC and explore the potential anti-inflammatory effects of Medihoney and Manuka honey extract on inhibiting mast …

    soton Download PDF for Mechanisms of action of Manuka honey as a potential therapeutic agent for bladder pain syndrome/interstitial cystitis: clinical and laboratory studies (opens in a new tab)

  6. BCG therapy for upper urothelial carcinoma. literature review /

    … and examine bacillus Calmuette-Guerin (BCG) therapy, it’s history, mechanism and how it relates to the treatment of upper urothelial carcinoma. The information collected in this review should aid in the understanding of upper urothelial carcinoma as well as BCG therapy and how BCG therapy …

    vilnius Repository record for BCG therapy for upper urothelial carcinoma. literature review / (opens in a new tab)

  7. Αξιολόγηση της έκφρασης βιολογικών δεικτών σε ασθενείς με επιφανειακό καρκίνο της ουροδόχου κύστης υπό συμπληρωματική ενδοκυστική θεραπεία

    This study investigates whether the use of intravesical treatment regimes affects biomarkers CD10, Her2, Ki67, p53, E-cadherin, B-catenin in superficial bladder cancer. The 6 tumour markers were studied in the biopsy material of the 1st TUR-BT and 2nd TUR-BT respectively. All of these studies were …

    greece Repository record for Αξιολόγηση της έκφρασης βιολογικών δεικτών σε ασθενείς με επιφανειακό καρκίνο της ουροδόχου κύστης υπό συμπληρωματική ενδοκυστική θεραπεία (opens in a new tab)